Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10052374
Compositions, methods and uses for dengue virus serotype-4 constructs
granted -
US 10052371
Compositions and methods for treatment of cancer using bacteria
granted -
US 10052369
Aquaporin 2 protects cattle from ticks and tick-borne parasites
granted -
US 10052349
Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
granted -
US 10052362
Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions
granted -
US 10051880
Hydroxybutyrate ester and medical use thereof
granted -
US 10053514
Human bispecific EGFRvIII and CD3 antibody engaging molecules
granted -
US 10053417
Neprilysin inhibitors
granted -
US 10052393
Multifunctional nanomaterials for the treatment of cancer
granted -
US 10052382
Methods for using antibodies for 3′ iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides
granted -
US 10052363
Mesenchymal stem cells for the treatment of CNS diseases
granted -
CA 3046406
PRODUIT DE REMPLACEMENT DE FACTEUR DE COAGULATION SANGUINE POUR UTILISATION DANS LE TRAITEMENT PROPHYLACTIQUE OU THERAPEUTIQUE DES HEMORRAGIES
granted -
US 10047152
Human antibodies to fel D1 and methods of use thereof
granted -
US 10046024
Cyclic-GluR6 analogs, methods of treatment and use
granted -
US 10047082
Octahydro fused azadecalin glucocorticoid receptor modulators
granted -
US 10046010
Methods of generating mesenchymal stem cells which secrete neurotrophic factors
granted -
US 10046045
Vaccine compositions and uses thereof
granted -
US 10047122
Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
granted -
US 10046057
Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy
granted -
US 10046036
Chemically modified cystathionine β-synthase enzyme for treatment of homocystinuria
granted -
US 10046028
Methods and compositions for modulating PD1
granted -
US 10046068
Saccharide conjugates
granted -
US 10045941
Method for formulating large diameter synthetic membrane vesicles
granted -
US 10046012
Multipotent postnatal stem cells from human periodontal ligament and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.